Agenus Inc.

Status: Publicly traded

Direct answer

Agenus Inc. is publicly traded on NASDAQ under the ticker AGEN.

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies. Agenus is also actively involved in...

Can you invest in Agenus Inc.?

Yes. Agenus Inc. trades publicly on NASDAQ as AGEN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Agenus Inc.

Detailed equity research is provided by MarketSnap.